Sabine Hertle
Impact in
- Hematology top 10%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 3
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Valeria Santini (3 shared papers)Huanling Zhu (1 shared paper)Catherine Tribouley (1 shared paper)Zhijian Xiao (2 shared papers)Xiao‐Jun Huang (1 shared paper)Mikkael A. Sekeres (3 shared papers)Hans D. Menssen (1 shared paper)Jianyong Li (1 shared paper)
- Journals
- Blood (4 papers)British Journal of Cancer (1 paper)HemaSphere (1 paper)Future Oncology (1 paper)Clinical Lymphoma Myeloma & Leukemia (1 paper)
- Partner nations
- SwitzerlandItalyUnited States
In The Last Decade
Sabine Hertle
8 papers receiving 188 citations
Peers
Comparison fields: 5 of 25
- Hematology 139
- Genetics 100
- Rheumatology 49
- Gastroenterology 16
- Oncology 45
Countries citing papers authored by Sabine Hertle
This map shows the geographic impact of Sabine Hertle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sabine Hertle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sabine Hertle more than expected).
Fields of papers citing papers by Sabine Hertle
This network shows the impact of papers produced by Sabine Hertle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sabine Hertle. The network helps show where Sabine Hertle may publish in the future.
Co-authors
The 25 scholars most cited alongside Sabine Hertle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 78 | |
| 2 | 2019 | 37 | |
| 3 | 2023 | 23 | |
| 4 | 2020 | 23 | |
| 5 | 2020 | 21 | |
| 6 | 2022 | 4 | |
| 7 | 2019 | 2 | |
| 8 | 2018 | 1 |
About Sabine Hertle
Sabine Hertle is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Oncology and Rheumatology, having authored 8 papers that have together received 189 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Eosinophilic Disorders and Syndromes (2 papers), Gastrointestinal Tumor Research and Treatment (1 paper), CAR-T cell therapy research (1 paper) and Gastrointestinal disorders and treatments (1 paper). The work is most often cited by research in Hematology (139 citations), Genetics (100 citations), Rheumatology (49 citations), Gastroenterology (16 citations) and Oncology (45 citations). Sabine Hertle has collaborated with scholars based in Switzerland, Italy and United States. Frequent co-authors include Valeria Santini, Huanling Zhu, Catherine Tribouley, Zhijian Xiao, Xiao‐Jun Huang, Mikkael A. Sekeres, Hans D. Menssen, Jianyong Li, Jianmin Wang and Aristoteles Giagounidis. Their work appears in journals such as Blood, British Journal of Cancer, HemaSphere, Future Oncology and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.